FDS Director Sells 2,925 Shares After Option Exercise 鈥� Ownership Unchanged

Q: How many FactSet (FDS) shares did director James McGonigle sell on 14 July 2025?

He sold 2,925 shares in three open-market transactions.

Q: What was the total value of the shares sold based on the reported weighted average prices?

Approximately $1.32 million (2,925 shares 脳 鈮�$451 average price).

Q: Did the director's ownership stake in FDS change after the transactions?

No. Beneficial ownership returned to 4,461 shares , the same level held before the option exercises.

Q: What were the exercise prices of the options exercised?

Options were exercised at $271.51 (2,010 shares) and $318.20 (915 shares).

Q: When were the exercised options originally granted and when do they expire?

The $271.51 options were granted 15 Jan 2020 (expire 15 Jan 2027); the $318.20 options were granted 15 Jan 2021 (expire 15 Jan 2028).

[Form 4] Regal Rexnord Corporation Insider Trading Activity

Filing Impact

(Low)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

FactSet Research Systems Inc. (FDS) 鈥� Form 4 insider transaction

Director James J. McGonigle reported a same-day option exercise and sale on 14 July 2025:

Options exercised: 2,010 shares at $271.51 and 915 shares at $318.20 (total 2,925 shares) stemming from 2020 and 2021 non-employee director grants.
Shares sold: 2,925 shares in three open-market lots at weighted average prices of $449.93, $451.05 and $451.98, raising roughly $1.32 million.
Post-transaction holding: 4,461 common shares held directly鈥攗nchanged from the level before the exercise/sale sequence.

The activity represents a routine cashless exercise where all shares obtained from the options were immediately sold. No new shares were added to, or removed from, the director鈥檚 long-term stake; therefore, the filing is viewed as neutral from a corporate-governance and liquidity standpoint and immaterial to FDS鈥檚 capital structure.

Insights

TL;DR: Routine cashless exercise; no change in insider ownership, minimal market impact.

The director exercised two tranches of fully-vested options (strike prices well below the $450 spot level) and liquidated the resulting shares, generating roughly $1.3 million in proceeds. Because the 2,925 shares sold exactly match the 2,925 acquired, beneficial ownership reverts to 4,461 shares鈥攊dentical to the pre-transaction level. The volume represents less than 0.01 % of FDS鈥檚 outstanding shares and should not affect float or trading dynamics. Insider-sale signal risk is modest, as the transaction is typical end-of-option-cycle monetisation rather than outright reduction of an existing stake.

TL;DR: Governance-neutral filing; aligns with standard director compensation practices.

The options exercised were granted in 2020-2021 and vested on three-year anniversaries, consistent with FactSet鈥檚 equity-based compensation plan. Immediate sale implies a cash-settlement approach, common for outside directors who diversify rather than accumulate large positions. No red flags on timing or volume relative to blackout periods. Because ownership remains steady and no discretionary share disposals occurred, the event is governance-neutral and non-impactful for shareholder voting or compensation concerns.

07/15/2025 - 04:53 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Lang Brooke

(Last)

(First)

(Middle)

111 WEST MICHIGAN STREET

(Street)

MILWAUKEE

53203

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
REGAL REXNORD CORP [ RRX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP and President, PES*

3. Date of Earliest Transaction (Month/Day/Year)
07/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/11/2025		F		239	D	$151.89	6,239.896	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Appreciation Rights	$154.2							02/23/2024⁽¹⁾	02/23/2033	Common Stock	969		969	D
Stock Appreciation Rights	$168.47							02/23/2025⁽¹⁾	02/23/2034	Common Stock	2,983		2,983	D

Explanation of Responses:

1. The Stock Appreciation Rights vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant.

Remarks:

Executive Vice President and President of Power Efficiency Solutions*

	/s/ Hugo Dubovoy Jr., as Power of Attorney	07/15/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

How many FactSet (FDS) shares did director James McGonigle sell on 14 July 2025?

He sold 2,925 shares in three open-market transactions.

What was the total value of the shares sold based on the reported weighted average prices?

Approximately $1.32 million (2,925 shares 脳鈮�$451 average price).

Did the director's ownership stake in FDS change after the transactions?

No. Beneficial ownership returned to 4,461 shares, the same level held before the option exercises.

What were the exercise prices of the options exercised?

Options were exercised at $271.51 (2,010 shares) and $318.20 (915 shares).

When were the exercised options originally granted and when do they expire?

The $271.51 options were granted 15 Jan 2020 (expire 15 Jan 2027); the $318.20 options were granted 15 Jan 2021 (expire 15 Jan 2028).

AG真人官方

[Form 4] Regal Rexnord Corporation Insider Trading Activity

Insights

FAQ

How many FactSet (FDS) shares did director James McGonigle sell on 14 July 2025?

What was the total value of the shares sold based on the reported weighted average prices?

Did the director's ownership stake in FDS change after the transactions?

What were the exercise prices of the options exercised?

When were the exercised options originally granted and when do they expire?

NYSE:RRX

RRX Rankings

RRX Latest News

RRX Latest SEC Filings

RRX Stock Data

AG真人官方

Trending News

[Form 4] Regal Rexnord Corporation Insider Trading Activity

Insights

Equity Analyst neutral

Corporate Governance Specialist neutral

FAQ

How many FactSet (FDS) shares did director James McGonigle sell on 14 July 2025?

What was the total value of the shares sold based on the reported weighted average prices?

Did the director's ownership stake in FDS change after the transactions?

What were the exercise prices of the options exercised?

When were the exercised options originally granted and when do they expire?

NYSE:RRX

RRX Rankings

RRX Latest News

RRX Latest SEC Filings

RRX Stock Data